Company · CIK 0001622057 · SIC 2834 — Pharmaceutical Preparations
Nascent Biotech Inc. · NBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2018 JForm 4 → | Oct 2, 11:58 am EDT | Brandon PriceSenior VP Business Development, Director, 10% Owner | 83,629 | $0.2787 | $23,312 | 1,191,172 | — | plan? late |
| Jun 28, 2018 JForm 4 → | Oct 2, 11:55 am EDT | Sean CarrickPresident & CEO, Director, 10% Owner | 139,382 | $0.2788 | $38,853 | 1,727,170 | — | plan? late |
| Jun 28, 2018 JForm 4 → | Oct 2, 11:53 am EDT | Lowell Thomas HoldenCFO, Director | 83,625 | $0.2788 | $23,311 | 1,016,172 | — | plan? late |
| Aug 14, 2017 JForm 4 → | Jun 11, 2018, 11:31 am EDT | Douglas John KarasDirector | 50,000 | $0.22 | $11,000 | 60,000 | — | plan? late |
| Jun 29, 2017 JForm 4 → | Oct 10, 7:37 am EDT | Brandon PriceSenior VP Business Development, Director, 10% Owner | 119,032 | $0.257 | $30,595 | 1,084,732 | — | plan? late |
| Jun 29, 2017 JForm 4 → | Oct 10, 7:36 am EDT | Lowell Thomas HoldenCFO, Director | 129,032 | $0.2565 | $33,095 | 919,732 | — | plan? late |
| Jun 29, 2017 JForm 4 → | Oct 10, 7:34 am EDT | Sean CarrickPresident & CEO, Director, 10% Owner | 198,387 | $0.257 | $50,992 | 1,549,753 | — | plan? late |
| Jun 26, 2017 JForm 4 → | Jun 5, 2018, 2:20 pm EDT | Brandon PriceSenior VP Business Development, Director, 10% Owner | 141,843 | $0.2535 | $35,963 | 1,107,543 | — | plan? late |
| Jun 26, 2017 JForm 4 → | Jun 5, 2018, 2:20 pm EDT | Lowell Thomas HoldenCFO, Director | 141,843 | $0.2535 | $35,963 | 932,547 | — | plan? late |
| Jun 26, 2017 JForm 4 → | Jun 5, 2018, 2:19 pm EDT | Sean CarrickPresident & CEO, Director, 10% Owner | 236,422 | $0.2535 | $59,941 | 1,587,788 | — | plan? late |
| Mar 28, 2017 JForm 4 → | Apr 4, 5:17 pm EDT | Lowell Thomas HoldenCFO, Director | 38,213 | $0.38 | $14,521 | 790,700 | — | plan? late |
| Mar 28, 2017 JForm 4 → | Apr 4, 5:16 pm EDT | Brandon PriceSenior VP Business Development, Director, 10% Owner | 38,213 | $0.38 | $14,521 | 965,700 | — | plan? late |
| Mar 28, 2017 JForm 4 → | Apr 4, 5:16 pm EDT | Sean CarrickPresident & CEO, Director, 10% Owner | 63,688 | $0.38 | $24,201 | 1,351,366 | — | plan? late |
| Dec 30, 2016 JForm 4 → | Jan 9, 2017, 8:26 pm EST | Brandon PriceSenior VP Business Development, Director, 10% Owner | 7,800 | $0.35 | $2,730 | 927,487 | — | plan? late |
| Dec 30, 2016 JForm 4 → | Jan 9, 2017, 8:25 pm EST | Sean CarrickPresident & CEO, Director, 10% Owner | 13,000 | $0.35 | $4,550 | 1,287,678 | — | plan? late |
| Dec 30, 2016 JForm 4 → | Jan 9, 2017, 8:22 pm EST | Lowell Thomas HoldenCFO, Director | 7,800 | $0.35 | $2,730 | 752,487 | — | plan? late |
| Oct 8, 2015 PForm 4/A → | Jan 5, 2016, 5:24 pm EST | Sean CarrickPrincipal Executive Officer, Director | 1,500 | $0.20 | $300 | 1,227,601 | +0.12% | plan? |
| Sep 4, 2015 JForm 4/A → | Jan 5, 2016, 5:56 pm EST | Lowell Thomas HoldenCFO, Director | 617,346 | $1.45 | $895,152 | 717,346 | — | plan? |
| Sep 4, 2015 JForm 4/A → | Jan 5, 2016, 5:51 pm EST | Brandon PriceSenior VP Business Development, Director | 617,346 | $1.45 | $895,152 | 892,346 | — | plan? |
| Sep 4, 2015 JForm 4/A → | Jan 5, 2016, 5:24 pm EST | Sean CarrickPrincipal Executive Officer, Director | 1,028,901 | $1.45 | $1,491,906 | 1,226,101 | — | plan? |
| Sep 4, 2015 PForm 4 → | Oct 13, 4:38 pm EDT | Lowell Thomas HoldenCFO, Director | 617,346 | $1.45 | $895,152 | 717,346 | +617% | plan? late amended |
| Sep 4, 2015 PForm 4 → | Oct 13, 4:37 pm EDT | Sean CarrickPrincipal Executive Officer, Director | 1,030,401 | $1.45 | $1,492,206 | 1,227,601 | +523% | plan? late amended |
| Sep 4, 2015 PForm 4 → | Oct 13, 4:37 pm EDT | Brandon PriceSenior VP Business Development, Director | 617,346 | $1.45 | $895,152 | 892,346 | +224% | plan? late amended |
| Apr 3, 2015 PForm 4 → | Jun 11, 2018, 11:31 am EDT | Douglas John KarasDirector | 10,000 | $1.00 | $10,000 | 10,000 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.